Harshitha Dudipala, MD (@hersheydudipala) 's Twitter Profile
Harshitha Dudipala, MD

@hersheydudipala

UCSD Heme/Onc Fellow @UCSDCancer ☀️ | Residency @BMCimRES | @NEOMEDedu alum | Mental Health Advocate | #WomeninMedicine | Polaroid Photography Enthusiast 📸

ID: 1665038446811807745

calendar_today03-06-2023 16:51:29

47 Tweet

136 Followers

218 Following

Harshitha Dudipala, MD (@hersheydudipala) 's Twitter Profile Photo

Excited to share some bench research from medical school that was recently published in Methods in Molecular Biology book series! Angiogenesis is fascinating in itself, and here we explore different methods to assess angiogenesis using Matrigel. link.springer.com/protocol/10.10…

Harshitha Dudipala, MD (@hersheydudipala) 's Twitter Profile Photo

Check out our new review article regarding incidence, pathogenesis, and management of non-clear cell renal cell carcinoma! Thank you Rana McKay, MD, FASCO for all your guidance! UC San Diego Health Moores Cancer Center journals.sagepub.com/doi/10.1177/17…

Rohan Ganti, MD MPH (@rohangantimd) 's Twitter Profile Photo

1/4 Ever thought about digging deeper into antibiotic prescriptions in AECOPD? Dr. Rob Fain did and asked the question of if CRP could help us guide antibiotic usage in AECOPD. What did we learn?

1/4

Ever thought about digging deeper into antibiotic prescriptions in AECOPD?  Dr. Rob Fain did and asked the question of if CRP could help us guide antibiotic usage in AECOPD. What did we learn?
Rohan Ganti, MD MPH (@rohangantimd) 's Twitter Profile Photo

1/5 Are we screening our COPD patients' symptoms appropriately? Dr. Tatyana Nguyen sought to find this out. Recent GOLD criteria to dictate COPD treatment are as below, but what are CAT and mMRC?

1/5 Are we screening our COPD patients' symptoms appropriately? Dr. Tatyana Nguyen sought to find this out.

Recent GOLD criteria to dictate COPD treatment are as below, but what are CAT and mMRC?
Harshitha Dudipala, MD (@hersheydudipala) 's Twitter Profile Photo

Graduated from internal medicine residency at Boston University Medical Center! It’s been an amazing 3 years, and I couldn’t have asked for a better place to complete my training. Thank you BU/BMC IM Residency for helping me get one step closer to my dreams. UC San Diego Health Moores Cancer Center here I come :)

Graduated from internal medicine residency at Boston University Medical Center! It’s been an amazing 3 years, and I couldn’t have asked for a better place to complete my training. Thank you <a href="/BMCimRES/">BU/BMC IM Residency</a> for helping me get one step closer to my dreams. <a href="/UCSDCancer/">UC San Diego Health Moores Cancer Center</a> here I come :)
Rohan Ganti, MD MPH (@rohangantimd) 's Twitter Profile Photo

Residency grad ✅. Thank you to BU/BMC IM Residency for supporting my growth for the past 3 years & my entire community. And forever grateful for being awarded Ariel Weisman excellence in teaching award. I owe it to all my co-residents who have become family.

Residency grad  ✅.   Thank you to <a href="/BMCimRES/">BU/BMC IM Residency</a> for supporting my growth for the past 3 years &amp; my entire community. 

And forever grateful for being awarded Ariel Weisman excellence in teaching award.  I owe it to all my co-residents who have become family.
Harshitha Dudipala, MD (@hersheydudipala) 's Twitter Profile Photo

Wanted to share an interesting case of a neuroendocrine tumor that transformed from secreting one type of peptide hormone to another! url.us.m.mimecastprotect.com/s/0A2CCqx5D4S8… BU/BMC IM Residency

UCSD Hematology/Oncology Fellowship (@hemucsd) 's Twitter Profile Photo

First year fellow, Harshitha Dudipala, MD, and her mentor, Rana McKay, MD, FASCO, are shining at GU ASCO this week! Congratulations on your amazing work evaluating molecular profiles in intraductal prostate cancer!

First year fellow, <a href="/HersheyDudipala/">Harshitha Dudipala, MD</a>, and her mentor, <a href="/DrRanaMcKay/">Rana McKay, MD, FASCO</a>, are shining at GU ASCO this week! Congratulations on your amazing work evaluating molecular profiles in intraductal prostate cancer!
Harshitha Dudipala, MD (@hersheydudipala) 's Twitter Profile Photo

Thank you Caris Life Sciences POA GU Working Group for inviting me last night to present my work on molecular alterations in intraductal prostate cancer: found to have more DNA repair alternations, high DLL3 expression, increased NEPC signature — suggestive of an aggressive subtype #GU25

Thank you <a href="/carisls/">Caris Life Sciences</a> POA GU Working Group for inviting me last night to present my work on molecular alterations in intraductal prostate cancer: found to have more DNA repair alternations, high DLL3 expression, increased NEPC signature — suggestive of an aggressive subtype #GU25
Harshitha Dudipala, MD (@hersheydudipala) 's Twitter Profile Photo

Awesome #ResearchToPractice Symposium regarding management of RCC by panelists Rana McKay, MD, FASCO Tian Zhang, MD, MHS Thomas Hutson, DO, PharmD, PhD FACP and moderator Sumanta K. Pal, MD, FASCO — review of IO and TKI in ccRCC, optimal treatment of relapsed/refractory RCC, and role of HIF-2a inhibitors in VHL-associated RCC #GU25

Awesome #ResearchToPractice Symposium regarding management of RCC by panelists <a href="/DrRanaMcKay/">Rana McKay, MD, FASCO</a> <a href="/TiansterZhang/">Tian Zhang, MD, MHS</a> <a href="/DrTHut/">Thomas Hutson, DO, PharmD, PhD FACP</a> and moderator <a href="/montypal/">Sumanta K. Pal, MD, FASCO</a> — review of IO and TKI in ccRCC, optimal treatment of relapsed/refractory RCC, and role of HIF-2a inhibitors in VHL-associated RCC #GU25